Therefore, we believe that further study of TRIM28 modulation of ER α and PR activity will provide the insight towards developing non-hormonal therapy for endometrial diseases and, more importantly, multiple systematic diseases including the immune disturbances, muscular hypotrophy and obesity that have been linked to TRIM28 deletion11–13. This evidence concerns the gene TRIM28 and Obesity.